Albert Nathan

Albert Nathan is an experienced sales leader currently serving as the Executive Area Manager for Rare Diseases in HAE and Hematology at CSL Behring Canada. With a proven track record in the bio-pharmaceutical and pharmaceutical markets, they have built strong relationships within the patient organization community and implemented innovative, patient-focused strategies. Albert has a history of mentoring teams and successfully launching key programs in rare diseases, drawing on their extensive expertise in areas such as Hereditary Angioedema and Hemophilia. Prior to their current role, they held various positions in sales and training across notable companies like AstraZeneca and Bristol-Myers Squibb. Albert holds a B.A. in Business Administration with a focus on Finance.